ChemPartner PharmaTech Co Ltd (300149) — Cash Flow Reinvestment Rate
ChemPartner PharmaTech Co Ltd (300149) has a Cash Flow Reinvestment Rate of 2.91x as of June 2023, reinvesting CN¥82.22 Million (capex CN¥66.62 Million plus investments CN¥-15.60 Million) from operating cash flow of CN¥28.21 Million. Check 300149 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ChemPartner PharmaTech Co Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for ChemPartner PharmaTech Co Ltd across 19 annual periods. Explore cash flow to debt ratio of ChemPartner PharmaTech Co Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for ChemPartner PharmaTech Co Ltd (2007–2025)
Year-by-year capital reinvestment analysis for ChemPartner PharmaTech Co Ltd. For live market cap and broader valuation context, see ChemPartner PharmaTech Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | CN¥101.07 Million | CN¥190.50 Million | CN¥62.47 Million | ▲ +28.5% |
| 2024 | 0.41x | CN¥69.47 Million | CN¥168.21 Million | CN¥69.25 Million | ▼ -71.9% |
| 2023 | 1.47x | CN¥221.69 Million | CN¥150.99 Million | CN¥201.29 Million | ▼ -22.9% |
| 2022 | 1.90x | CN¥499.85 Million | CN¥262.46 Million | CN¥336.20 Million | ▲ +137.9% |
| 2021 | 0.80x | CN¥302.77 Million | CN¥378.22 Million | CN¥286.00 Million | ▼ -33.3% |
| 2020 | 1.20x | CN¥412.05 Million | CN¥343.16 Million | CN¥394.03 Million | ▲ +0.3% |
| 2019 | 1.20x | CN¥257.54 Million | CN¥215.07 Million | CN¥254.23 Million | ▲ +103.7% |
| 2018 | 0.59x | CN¥142.94 Million | CN¥243.19 Million | CN¥109.88 Million | ▼ -51.5% |
| 2017 | 1.21x | CN¥76.93 Million | CN¥63.43 Million | CN¥4.21 Million | ▲ +260.8% |
| 2016 | 0.34x | CN¥23.95 Million | CN¥71.26 Million | CN¥10.45 Million | ▲ +33.6% |
| 2015 | 0.25x | CN¥25.33 Million | CN¥100.69 Million | CN¥25.33 Million | ▼ -80.5% |
| 2014 | 1.29x | CN¥76.93 Million | CN¥59.63 Million | CN¥76.93 Million | ▼ -5.4% |
| 2013 | 1.36x | CN¥63.17 Million | CN¥46.32 Million | CN¥63.17 Million | ▼ -39.9% |
| 2012 | 2.27x | CN¥124.91 Million | CN¥55.09 Million | CN¥124.91 Million | ▲ +25.6% |
| 2011 | 1.81x | CN¥21.06 Million | CN¥11.66 Million | CN¥21.06 Million | ▲ +122.6% |
| 2010 | 0.81x | CN¥16.89 Million | CN¥20.81 Million | CN¥16.89 Million | ▼ -42.8% |
| 2009 | 1.42x | CN¥18.83 Million | CN¥13.28 Million | CN¥18.83 Million | ▲ +26.4% |
| 2008 | 1.12x | CN¥24.33 Million | CN¥21.70 Million | CN¥24.33 Million | ▲ +285.7% |
| 2007 | 0.29x | CN¥6.45 Million | CN¥22.19 Million | CN¥6.45 Million | — |